Aesthetic plastic surgery · 2026
Characterization of Sex-Specific Immediate Breast Reconstruction Trends Following Mastectomy Between 2005 and 2023.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Quick Joseph D, Rashidi Keyvon, Potoczak Patrick, Schafer Rachel E, Schwarz Graham S
Аннотация
BACKGROUND: Immediate breast reconstruction (IBR) following mastectomy is a standard of care in female patients; however, the role and characteristics of IBR in male patients remain poorly defined. Here, the authors aim to investigate IBR trends in both males and females.
METHODS: A retrospective analysis of male and female patients undergoing mastectomy from 2005 to 2023 was conducted using the National Surgical Quality Improvement Project (NSQIP) database (n = 450,925; male = 7,445, female=443,480). The most common methods of IBR (≥ 0.1% of patients) were identified using Current Procedural Terminology (CPT) codes. Demographics, comorbidities, outcomes, and rates of IBR were analyzed using independent t-tests and Chi-square tests. The association between year and rate of IBR by sex was investigated using a logistic regression model.
RESULTS: From 2005 to 2023, 21.0% of male (1,562) and 55.4% of female (245,750) patients underwent IBR following mastectomy (p < 0.0001). Among patients undergoing IBR, the most common male breast reconstruction procedures were nipple-areolar complex reconstruction (43.9%) and tissue expander placement (9.4%), whereas the most common female breast reconstruction procedures were tissue expander placement (42.7%) and implant placement (23.3%). The 30-day IBR surgical-site complication rate was low, with females suffering more morbidity than males (5.0% v. 3.2%, p < 0.001). There was an association between year and rate of IBR for both male (β = 0.2036, 95% CI 0.1871-0.2203, p < 0.0001) and female (β = 0.0428, 95% CI 0.0415-0.0440, p < 0.0001) patients.
CONCLUSIONS: Compared to female patients, IBR remains low in male patients. However, the year-to-year growth in IBR is encouraging and may indicate increasing awareness and acceptance of reconstruction in male patients.
LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
METHODS: A retrospective analysis of male and female patients undergoing mastectomy from 2005 to 2023 was conducted using the National Surgical Quality Improvement Project (NSQIP) database (n = 450,925; male = 7,445, female=443,480). The most common methods of IBR (≥ 0.1% of patients) were identified using Current Procedural Terminology (CPT) codes. Demographics, comorbidities, outcomes, and rates of IBR were analyzed using independent t-tests and Chi-square tests. The association between year and rate of IBR by sex was investigated using a logistic regression model.
RESULTS: From 2005 to 2023, 21.0% of male (1,562) and 55.4% of female (245,750) patients underwent IBR following mastectomy (p < 0.0001). Among patients undergoing IBR, the most common male breast reconstruction procedures were nipple-areolar complex reconstruction (43.9%) and tissue expander placement (9.4%), whereas the most common female breast reconstruction procedures were tissue expander placement (42.7%) and implant placement (23.3%). The 30-day IBR surgical-site complication rate was low, with females suffering more morbidity than males (5.0% v. 3.2%, p < 0.001). There was an association between year and rate of IBR for both male (β = 0.2036, 95% CI 0.1871-0.2203, p < 0.0001) and female (β = 0.0428, 95% CI 0.0415-0.0440, p < 0.0001) patients.
CONCLUSIONS: Compared to female patients, IBR remains low in male patients. However, the year-to-year growth in IBR is encouraging and may indicate increasing awareness and acceptance of reconstruction in male patients.
LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .